Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease

被引:49
|
作者
Tremblay-Mercier, Jennifer [1 ]
Madjar, Cecile [1 ,2 ]
Das, Samir [2 ]
Binette, Alexa Pichet [1 ,3 ]
Dyke, Stephanie O. M. [2 ,3 ,4 ]
Etienne, Pierre [1 ,3 ]
Lafaille-Magnan, Marie-Elyse [1 ,3 ,5 ]
Remz, Jordana [1 ]
Bellec, Pierre [6 ,7 ]
Collins, D. Louis [3 ,4 ]
Rajah, M. Natasha [1 ,3 ]
Bohbot, Veronique [1 ,3 ]
Leoutsakos, Jeannie-Marie [8 ]
Iturria-Medina, Yasser [2 ,3 ,4 ]
Kat, Justin [1 ,2 ]
Hoge, Richard D. [2 ,3 ,4 ,7 ]
Gauthier, Serge [1 ,3 ,9 ]
Tardif, Christine L. [3 ,4 ]
Chakravarty, M. Mallar [1 ,3 ]
Poline, Jean-Baptiste [2 ,3 ,4 ]
Rosa-Neto, Pedro [1 ,3 ,4 ,9 ]
Evans, Alan C. [1 ,2 ,3 ,4 ]
Villeneuve, Sylvia [1 ,2 ,3 ,4 ]
Poirier, Judes [1 ,3 ]
Breitner, John C. S. [1 ,3 ]
机构
[1] Douglas Mental Hlth Inst Res Ctr, StoP AD Ctr, Montreal, PQ, Canada
[2] McGill Univ, McGill Ctr Integrat Neurosci, Montreal Neurol Inst, Montreal, PQ, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, Montreal, PQ, Canada
[5] Jewish Gen Hosp Montreal, Ctr Child Dev & Mental Hlth, Montreal, PQ, Canada
[6] CRIUGM Univ Montreal, Montreal, PQ, Canada
[7] Univ Montreal, Montreal, PQ, Canada
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] McGill Univ, Res Ctr Studies Aging, Montreal, PQ, Canada
关键词
Pre-symptomatic Alzheimer Disease; Biomarkers; Observational cohort; Open Science; Neuroimaging; Cerebrospinal Fluid proteins; AGE-OF-ONSET; IDENTIFICATION TEST; COGNITIVE DECLINE; DEMENTIA; RISK; ASSOCIATION; GENOTYPE; HISTORY;
D O I
10.1016/j.nicl.2021.102733
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
To move Alzheimer Disease (AD) research forward it is essential to collect data from large cohorts, but also make such data available to the global research community. We describe the creation of an open science dataset from the PREVENT-AD (PResymptomatic EValuation of Experimental or Novel Treatments for AD) cohort, composed of cognitively unimpaired older individuals with a parental or multiple-sibling history of AD. From 2011 to 2017, 386 participants were enrolled (mean age 63 years old +/- 5) for sustained investigation among whom 349 have retrospectively agreed to share their data openly. Repositories are findable through the unified interface of the Canadian Open Neuroscience Platform and contain up to five years of longitudinal imaging data, cerebral fluid biochemistry, neurosensory capacities, cognitive, genetic, and medical information. Imaging data can be accessed openly at https://openpreventad.loris.ca while most of the other information, sensitive by nature, is accessible by qualified researchers at https://registeredpreventad.loris.ca. In addition to being a living resource for continued data acquisition, PREVENT-AD offers opportunities to facilitate understanding of AD pathogenesis.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer's disease (vol 14, e0226197, 2019)
    Oh, Angela J.
    Amore, Giulia
    Sultan, William
    Asanad, Samuel
    Park, Jason C.
    Romagnoli, Martina
    La Morgia, Chiara
    Karanjia, Rustum
    Harrington, Michael G.
    Sadun, Alfredo A.
    PLOS ONE, 2020, 15 (02):
  • [42] Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET a longitudinal cohort study
    Schworer, Emily K.
    Zammit, Matthew
    Wang, Jiebiao
    Handen, Benjamin L.
    Betthauser, Tobey
    Laymon, Charles M.
    Tudorascu, Dana L.
    Cohen, Annie
    Zaman, Shahid H.
    Ances, Beau M.
    Mapstone, Mark
    Head, Elizabeth
    Christian, Bradley
    Hartley, Sigan L.
    LANCET NEUROLOGY, 2024, 23 (12): : 1214 - 1224
  • [43] APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset
    Rabipour, Sheida
    Rajagopal, Sricharana
    Yu, Elsa
    Pasvanis, Stamatoula
    Lafaille-Magnan, Marie-Elyse
    Breitner, John
    Rajah, M. Natasha
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 76 (01) : 97 - 119
  • [44] Elevated CSF p-tau181 and total-tau and reduced p-tau181/t-tau ratio in pre-symptomatic familial Alzheimer's disease
    Ringman, John M.
    Seltzer, Willam
    Cole, Greg
    Medina, Luis D.
    Rodriguez, Yaneth
    Varpetian, Arousiak
    Sokolow, Sophie
    Fitten, Jaime
    Ortiz, Freddy
    Cummings, Jeffrey L.
    NEUROLOGY, 2008, 70 (11) : A183 - A183
  • [45] Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer’s Disease: Findings from a Longitudinal Cohort Analysis
    J. Chandler
    M. Georgieva
    Urvi Desai
    N. Done
    A. Gomez-Lievano
    W. Ye
    A. Zhao
    D. Eid
    A. Hilts
    N. Kirson
    T. Schilling
    The Journal of Prevention of Alzheimer's Disease, 2024, 11 : 320 - 328
  • [46] Impact of Differential Rates of Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Findings from a Longitudinal Cohort Analysis
    Chandler, J.
    Georgieva, M.
    Desai, Urvi
    Done, N.
    Gomez-Lievano, A.
    Ye, W.
    Zhao, A.
    Eid, D.
    Hilts, A.
    Kirson, N.
    Schilling, T.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2024, 11 (02): : 310 - 319
  • [47] Explorative results from multistep screening for potential genetic risk loci of Alzheimer's disease in the longitudinal VITA study cohort
    Scholz, Claus-Juergen
    Weber, Heike
    Jungwirth, Susanne
    Danielczyk, Walter
    Reif, Andreas
    Tragl, Karl-Heinz
    Fischer, Peter
    Riederer, Peter
    Deckert, Juergen
    Gruenblatt, Edna
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (01) : 77 - 87
  • [48] Explorative results from multistep screening for potential genetic risk loci of Alzheimer’s disease in the longitudinal VITA study cohort
    Claus-Jürgen Scholz
    Heike Weber
    Susanne Jungwirth
    Walter Danielczyk
    Andreas Reif
    Karl-Heinz Tragl
    Peter Fischer
    Peter Riederer
    Jürgen Deckert
    Edna Grünblatt
    Journal of Neural Transmission, 2018, 125 : 77 - 87
  • [49] Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective
    Shokouhi, Sepideh
    Campbell, Desmond
    Brill, Aaron B.
    Gwirtsman, Harry E.
    BRAIN PATHOLOGY, 2016, 26 (05) : 664 - 671
  • [50] Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer ' s disease
    Wise-Brown, Alexandria
    Brangman, Sharon A.
    Henderson, J. Neil
    Willis-Parker, Monica
    Monroe, Stephanie
    Mintzer, Jacobo E.
    Grundman, Michael
    Smith, Janice
    Doody, Rachelle S.
    Lin, Helen
    Assman, Beverly
    Rippon, Gregory A.
    Gonzales, Rozanno
    Assuncao, Sheila Seleri
    ECLINICALMEDICINE, 2024, 73